- Article
Altered Plasma Endocannabinoids and Oxylipins in Adolescents with Major Depressive Disorders: A Case–Control Study
- Akash Chakravarty,
- Abinaya Sreetharan,
- Ester Osuna,
- Isabelle Herter-Aeberli,
- Isabelle Häberling,
- Jeannine Baumgartner,
- Gregor E. Berger and
- Martin Hersberger
Background: Pediatric Major Depressive Disorder (pMDD) is one of the leading causes of disability in adolescents. There is currently no single explanation that fully accounts for the cause of the disorder, but various factors, including dysregulation...